Evolent Health (EVH) Stock Statistics & Valuation Metrics

Evolent Health has a market cap or net worth of $1.05B. The enterprise value is $2.92B.

Evolent Health has 117,399,810 shares outstanding. The number of shares has decreased by -2.65% in one year.

Evolent Health’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -1.95%.

The current PE Ratio of Evolent Health is -20.94. Evolent Health’s PEG ratio is 3.28.

In the last 12 months, Evolent Health had revenue of 2.55B and earned -61.62M in profits. Earnings per share was -0.81.

In the last 12 months, operating cash flow was 18.42M and capital expenditures -28.14M, giving a free cash flow of -9.72M billion.

Evolent Health pays an annual dividend of ―, resulting in a dividend yield of ―

Evolent Health upcoming earnings date is Jul 30, 2025, TBA Not Confirmed.

Evolent Health as a current ratio of 0.85, with Debt / Equity ratio of 55.40%

In the past 12 months, Evolent Health has paid -1.41M in taxes.

Evolent Health EV to EBITDA ratio is 22.39, with an EV/FCF ratio of -309.99.

Evolent Health has $246.55M in cash and marketable securities with $870.10M in debt, giving a net cash position of $623.55M billion.

Gross margin is 23.42%, with operating margin of -1.58%, and net profit margin of -2.41%.

The average price target for Evolent Health is $15.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy